Detalhe da pesquisa
1.
Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Hospitalization Among Adults Aged ≥18 Years with Immunocompromising Conditions - VISION Network, September 2023-February 2024.
MMWR Morb Mortal Wkly Rep;
73(12): 271-276, 2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38547037
2.
Risk of COVID-19 Hospitalization and Protection Associated With mRNA Vaccination Among US Adults With Psychiatric Disorders.
Influenza Other Respir Viruses;
18(3): e13269, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38494192
3.
Interim Estimates of 2023-24 Seasonal Influenza Vaccine Effectiveness - United States.
MMWR Morb Mortal Wkly Rep;
73(8): 168-174, 2024 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38421935
4.
Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged ≥18 Years - VISION and IVY Networks, September 2023-January 2024.
MMWR Morb Mortal Wkly Rep;
73(8): 180-188, 2024 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38421945
5.
Vaccine Effectiveness Against Pediatric Influenza-A-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2022-2023 Season: VISION Network.
Clin Infect Dis;
78(3): 746-755, 2024 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37972288
6.
Clinical Epidemiology and Risk Factors for Critical Outcomes Among Vaccinated and Unvaccinated Adults Hospitalized With COVID-19-VISION Network, 10 States, June 2021-March 2023.
Clin Infect Dis;
78(2): 338-348, 2024 02 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37633258
7.
Influenza vaccine effectiveness against influenza-A-associated emergency department, urgent care, and hospitalization encounters among U.S. adults, 2022-2023.
J Infect Dis;
2023 Dec 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38041853
8.
Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months-5 Years - VISION Network, United States, July 2022-June 2023.
MMWR Morb Mortal Wkly Rep;
72(33): 886-892, 2023 Aug 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37590187
9.
Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19-Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions - VISION Network, September 2022-April 2023.
Am J Transplant;
23(7): 1062-1076, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37394267
10.
Effectiveness of COVID-19 vaccines at preventing emergency department or urgent care encounters and hospitalizations among immunocompromised adults: An observational study of real-world data across 10 US states from August-December 2021.
Vaccine;
41(37): 5424-5434, 2023 08 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37479609
11.
Number needed to vaccinate with a COVID-19 booster to prevent a COVID-19-associated hospitalization during SARS-CoV-2 Omicron BA.1 variant predominance, December 2021-February 2022, VISION Network: a retrospective cohort study.
Lancet Reg Health Am;
23: 100530, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37333688
12.
Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19-Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions - VISION Network, September 2022-April 2023.
MMWR Morb Mortal Wkly Rep;
72(21): 579-588, 2023 May 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37227984
13.
Effectiveness of BNT162b2 COVID-19 Vaccination in Children and Adolescents.
Pediatrics;
151(5)2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37026401
14.
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022.
MMWR Morb Mortal Wkly Rep;
71(53): 1637-1646, 2023 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36921274
15.
Estimation of COVID-19 mRNA Vaccine Effectiveness and COVID-19 Illness and Severity by Vaccination Status During Omicron BA.4 and BA.5 Sublineage Periods.
JAMA Netw Open;
6(3): e232598, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36920396
16.
Protection From COVID-19 mRNA Vaccination and Prior SARS-CoV-2 Infection Against COVID-19-Associated Encounters in Adults During Delta and Omicron Predominance.
J Infect Dis;
227(12): 1348-1363, 2023 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36806690
17.
Vaccine Effectiveness Against Influenza-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2021-2022 Season, VISION Network.
J Infect Dis;
228(2): 185-195, 2023 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36683410
18.
Relationships Between Social Vulnerability and Coronavirus Disease 2019 Vaccination Coverage and Vaccine Effectiveness.
Clin Infect Dis;
76(9): 1615-1625, 2023 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36611252
19.
Protection of Two and Three mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized With COVID-19-VISION Network, August 2021 to March 2022.
J Infect Dis;
227(8): 961-969, 2023 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36415904
20.
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022.
MMWR Morb Mortal Wkly Rep;
71(5152): 1616-1624, 2022 Dec 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36580430